Caas Capital Management LP Relay Therapeutics, Inc. Transaction History

Caas Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$14.16 - $24.02 $1.07 Million - $1.82 Million	-75,598 Reduced 68.98%	34,000 $507,000
Q3 2022 Nov 14, 2022	BUY	$18.07 - $31.37 $1.98 Million - $3.44 Million	109,598 New	109,598 $2.45 Million
Q2 2021 Aug 16, 2021	SELL	$27.5 - $38.19 $1.81 Million - $2.51 Million	-65,790 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$32.52 - $61.53 $2.14 Million - $4.05 Million	65,790 New	65,790 $2.27 Million

206

156M

207K

40K

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $583M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Caas Capital Management LP with notifications on news.